1.CHONDROBLSTOMA ON TEMPOROMANDIBULAR JOINT, A CASE REPORT.
Hyun Ho CHANG ; Seung Yun HAN ; Hyung Mo AHN ; Won Jong CHOI ; Jae Seung KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1997;23(4):756-762
Chondroblastoma is a rare primary bone tumor which originates from cartilage, and represents approximate 1% af all bone tumor. The chondroblastoma arises most frequently from the epiphysis of the long bones with the humerus being the commonest site. It afflicts usually the young under 25 years with greater incidence in male. As there is no cartilage cell on craniofacial bone which is mainly fromed by intramembranous ossification, the chondroblastoma on the craniofacial bone is extremely rare. But the chondroblastoma recurred frequently in craniofacial bone when the mass is excised incompletely or curretted and, as the tumor has the outstanding ability of local invasiveness, it destructs the adjacent bone. In addition, it is difficult to diagnose differentially from sarcoma or giant cell tumor histopathologically. Due to the entities described above, it is necessary to remove the entire tumor mass as complete as possible, to treat with radiation pre or postoperatively for preventing from recurrence, and to observe for a long time. The chondroblastoma on temporal bone is rare and is difficult to diagnose and treat successfully. So we'd like to present a case of chondroblastoma which was originated from temporal side of TMJ with literatural review.
Cartilage
;
Chondroblastoma
;
Epiphyses
;
Giant Cell Tumors
;
Humans
;
Humerus
;
Incidence
;
Male
;
Recurrence
;
Sarcoma
;
Temporal Bone
;
Temporomandibular Joint*
2.Treatment of tuberculous bronchostenosis: Balloon bronchoplasty.
Joong Mo AHN ; Jung Gi IM ; Joon Koo HAN ; Jae Hyung PARK
Journal of the Korean Radiological Society 1993;29(3):431-436
The purpose of this study is to evaluate the efficacy of the balloon bronchoplasty in the treatment of the tuberculous bronchostenosis. Balloon bronchoplasty was performed in thirteen patients with stenosis of the left main bronchus (two with combined left upper and lower lobar bronchostenosis) using a inflatable balloon catheter under a fluoroscopic guide. We analysed the changes in the changes in the severity of dyspnea and wheezing, serial FEV1/FVC as a parameter of the airflow obstruction, and bronchial diameter and lung volume on chest radiographs. The extent of pulmonary tuberculosis was correlated with the improvement of FEV1/FVC. There was an improvement of dyspnea in 69%(9/13), decrease of wheezing in 69%(9/13), significant increase of FEV1/FVC in 18% (2/11). The increase of the bronchial diameter and lung volume were seen in 84%(11/13) and 53% (7/13), respectively. The significant increase of FEVI/FVC was seen in 28% (2/7) of the patients with lung involvement of tuberculosis less than one third of left upper lobe, whereas there was no increase in those of more than one third. There was no complication except transient leukocytosis, fever and blood-tinged sputum. In conclusion, balloon bronchoplasty is effective in the treatment of medically intractable tuberculous bronchostenosis, and can be considered as an initial method of treatment.
Bronchi
;
Catheters
;
Constriction, Pathologic
;
Dyspnea
;
Fever
;
Humans
;
Leukocytosis
;
Lung
;
Methods
;
Radiography, Thoracic
;
Respiratory Sounds
;
Sputum
;
Tuberculosis
;
Tuberculosis, Pulmonary
3.Treatment of tuberculous bronchostenosis: Balloon bronchoplasty.
Joong Mo AHN ; Jung Gi IM ; Joon Koo HAN ; Jae Hyung PARK
Journal of the Korean Radiological Society 1993;29(3):431-436
The purpose of this study is to evaluate the efficacy of the balloon bronchoplasty in the treatment of the tuberculous bronchostenosis. Balloon bronchoplasty was performed in thirteen patients with stenosis of the left main bronchus (two with combined left upper and lower lobar bronchostenosis) using a inflatable balloon catheter under a fluoroscopic guide. We analysed the changes in the changes in the severity of dyspnea and wheezing, serial FEV1/FVC as a parameter of the airflow obstruction, and bronchial diameter and lung volume on chest radiographs. The extent of pulmonary tuberculosis was correlated with the improvement of FEV1/FVC. There was an improvement of dyspnea in 69%(9/13), decrease of wheezing in 69%(9/13), significant increase of FEV1/FVC in 18% (2/11). The increase of the bronchial diameter and lung volume were seen in 84%(11/13) and 53% (7/13), respectively. The significant increase of FEVI/FVC was seen in 28% (2/7) of the patients with lung involvement of tuberculosis less than one third of left upper lobe, whereas there was no increase in those of more than one third. There was no complication except transient leukocytosis, fever and blood-tinged sputum. In conclusion, balloon bronchoplasty is effective in the treatment of medically intractable tuberculous bronchostenosis, and can be considered as an initial method of treatment.
Bronchi
;
Catheters
;
Constriction, Pathologic
;
Dyspnea
;
Fever
;
Humans
;
Leukocytosis
;
Lung
;
Methods
;
Radiography, Thoracic
;
Respiratory Sounds
;
Sputum
;
Tuberculosis
;
Tuberculosis, Pulmonary
4.A Clinicopathologic Study of 31 Cases with Ovarian Malignant Germ Cell Tumors.
Nam Won SEO ; Cheon Jun LEE ; Do Hyung KIM ; Un Mo AHN ; Tae Hong YEO ; Jun Houg KIM ; Sunn Ie AHN ; Dong Hwi KIM ; Un Dong PARK
Korean Journal of Obstetrics and Gynecology 2000;43(1):51-57
OBJECTIVE: The purpose of this study was to review the clinicopathologic features, recurrent rate, survival rate and controversable issues in the treatment of the ovarian malignant germ cell tumors. PATIENTS AND METHODS: From August, 1991 to November, 1998 thirty-one patients with malignant germ cell tumors of the ovary treated in the department of obstetrics and gynecology, Kosin University Medical college, were eligible and assessable. Demographic characteristics, symptoms, signs, stage, tumor grade, mode of therapy and results of follow up were reviewed retrospectively. RESULTS: The patients with malignant germ cell tumor constituted 6.37% of all ovarian malignancies during this period. Histologic subtypes were 8 dysgerminoma(25.8%), 7 endodermal sinus tumor(22.6%), 10 immature teratoma(32.3%), 3 mixed germ cell tumor(9.7%), 3 choriocarcinoma(9.7%). The age of the patients ranged from 10 to 40 years (mean +/-S.D.; 24.26 +/- 7.51). The most common symptom was abdominal pain(38.7%). Most had stageI(18 cases, 58.0%) or stageIII(5 cases, 16.2%) diseases. All patients underwent surgery as the initial treatment, and nine patients received more than one operation. Postoperative adjuvant chemotherapeutic regimens were VAC, VBP, EP, BEP, EMA, and EMA CO. The mean follow up duration was 26.0(+/- S.D.; +/- 20.3) months. The 2-year and 5-year survival rate were 91.97%(+/- S.E.; +/- 0.05) and 86.86%(+/- S.E.; +/- 0.07).
Endoderm
;
Female
;
Follow-Up Studies
;
Germ Cells*
;
Gynecology
;
Humans
;
Neoplasms, Germ Cell and Embryonal*
;
Obstetrics
;
Ovary
;
Retrospective Studies
;
Survival Rate
5.Presumed Necrotizing Viral Retinitis after Intravitreal Triamcinolone Injection: Case Report.
Jeong Mo HAN ; Jeeyun AHN ; Kyu Hyung PARK ; Se Joon WOO
Korean Journal of Ophthalmology 2011;25(6):451-454
A 56-year-old man presented with anterior chamber inflammation, increased intraocular pressure, peripheral retinal infiltration, and generalized retinal arterial obstruction suggesting acute retinal necrosis five months after intravitreal triamcinolone acetonide injection (IVTA). He was treated with intravenous antiviral agents and aspirin. Shortly after treatment, retinal infiltrations were resolved, and partial recanalization of the obstructed vessel was observed. Viral retinitis may occur as an opportunistic infection following IVTA due to the local immune modulatory effect of the steroid; hence, close observation following IVTA is necessary.
Antiviral Agents/therapeutic use
;
Aspirin/therapeutic use
;
Drug Therapy, Combination
;
Humans
;
Intravitreal Injections
;
Male
;
Middle Aged
;
Opportunistic Infections/*chemically induced/virology
;
Retinal Necrosis Syndrome, Acute/*chemically induced/virology
;
Triamcinolone Acetonide/administration & dosage/*adverse effects
6.An epidemiologic survey on cancer epidemic at pukcheju-gun.
Yoon Ok AHN ; Byung Joo PARK ; Jong Myon BAE ; Duk Hyung LEE ; Dong Jin KIM ; Jun Hwan KIM ; Jong Won KANG ; Yong Jin JUNG ; Dong Mo RHIE
Korean Journal of Epidemiology 1993;15(2):185-195
No abstract available.
7.Dectection of Ureaplasma urealyticum in Invasive Cervical Cancer Tissue.
Un Mo AHN ; Nam Won SEO ; Do Hyung KIM ; Tae Hong YEO ; Tae Kyoung KANG ; Jun Hong KIM ; Sunn Ie AHN ; Dong Hwi KIM ; Un Dong PARK
Korean Journal of Obstetrics and Gynecology 2001;44(4):663-667
OBJECTIVE: Mycoplasmas have been implicated in many diseases including cervicitis, urethritis, salpingitis, endometritis... and functioning as cofactors catalyzing the HIV disease state. The oncogenic potentiality of mycoplasma was only recently realized when they were shown causing chromosomal changes and in vitro cell transformations through gradual progressive chromsomal loss and translocation. Few study has been reported the prevalence of mycoplasma infection in human cancers and suggested that there was a connection between these organisms and human cancers. The objective of this study was to determine the relationship between Ureaplasma urealyticum infection and cervical cancer. METHODS: The detection frequency of Ureaplasma urealyticum in 52 invasive cervical cancer tissues and 17 normal cervical tissues was studied using PCR. RESULTS: U. urealyticum DNA was detected in 8 out of 52(15.4%) invasive cervical cancer tissues and 1 out of 17(5.9%) normal cervical tissues. No statistic significance was observed between the detection frequency of Ureaplasma urealyticum and clinicopathologic parameters. The prevalence of Ureaplasma urealyticum in invasive cervical tissues was 15.4% and this rate was higher than 5.9% in normal cervical tissues but there was no statistic significance. CONCLUSIONS: With respect to clinicopathologic parameters of cervical cancer, there was no significant relation between U. urealyticum infection and cervical cancer. There is, however, few study and case on cervical cancer internally and externally. It is considered that more studies on the subject with much cases should be made.
Carcinogenesis
;
DNA
;
Endometritis
;
Female
;
HIV
;
Humans
;
Mycoplasma
;
Mycoplasma Infections
;
Polymerase Chain Reaction
;
Prevalence
;
Salpingitis
;
Ureaplasma urealyticum*
;
Ureaplasma*
;
Urethritis
;
Uterine Cervical Neoplasms*
;
Uterine Cervicitis
8.Expression of MAGE 3 Gene Products in Uterine Cervical Carcinoma.
Tae Kyoung KANG ; Nam Won SEO ; Do Hyung KIM ; Un Mo AHN ; Tae Hong YEO ; Jun Hong KIM ; Sunn Ie AHN ; Dong Hwi KIM ; Un Dong PARK
Korean Journal of Obstetrics and Gynecology 2001;44(3):519-524
OBJECTIVE: The human MAGE 3 gene encodes tumor specific antigens that are recognized by autologue cytotoxic T lymphocytes (CTL). The MAGE 3 gene is expressed not only in melanoma but in the other malignant tumors as well. There is, however, little information on the expression of the gene in uterine cervical carcinomas. The author thus studied the expression of the MAGE 3 gene products in uterine cervical carcinoma and discuss the possibility of specific immunologic diagnosis using MAGE 3 gene products. METHODS: The expression of MAGE 3 gene product in 17 normal tissues of the cervix, 32 cervical intraepithelial neoplasia (8 CIN I, 10 CIN II, 14 CIS), and 43 invasive cervical carcinomas was studied by immunohistochemistry using anti-MAGE 3 mAb 57B in paraffin sections RESULTS: No expression of MAGE 3 gene product was detected in normal cervical tissues and in cervical intraepithelial neoplasias. The expression of MAGE 3 gene product was detected in 30.2% (13/43) of invasive cervical carcinomas. The MAGE 3 gene product was stained as a cytoplasmic protein in cancer cells. No statistically significant differences were observed between MAGE 3 gene product expression status and clinicopathologic parameters. CONCLUSIONS: The MAGE 3 gene products was expressed in invasive cervical carcinoma tissues.
Cervical Intraepithelial Neoplasia
;
Cervix Uteri
;
Cytoplasm
;
Female
;
Humans
;
Immunohistochemistry
;
Immunologic Tests
;
Melanoma
;
Paraffin
;
T-Lymphocytes, Cytotoxic
9.Idiopathic Calcium Pyrophosphate Dihydrate (CPPD) Crystal Deposition Disease in a Young Male Patient: A Case Report.
Joong Kyung AHN ; Hyung Jin KIM ; Eung Ho KIM ; Chan Hong JEON ; Hoon Suk CHA ; Chul Won HA ; Joong Mo AHN ; Eun Mi KOH
Journal of Korean Medical Science 2003;18(6):917-920
Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease is a disease of the elderly and extremely rare in young individuals. If young people develop CPPD crystal deposition disease, it may be associated with metabolic diseases such as hemochromatosis, hyperparathyroidism, hypophosphatasia, hypomagnesemia, Wilson's disease, hypothyroidism, gout, acromegaly, and X-linked hypophosphatemic rickets. Therefore, in young-onset polyarticular CPPD crystal deposition disease, investigation for predisposing metabolic conditions is warranted. We report a case of a young male patient with idiopathic CPPD crystal deposition disease, who did not have any evidences of metabolic diseases after thorough evaluations. As far as we know, this is the first report of a young male patient presented with idiopathic CPPD crystal deposition disease.
Adult
;
Calcium Pyrophosphate/*metabolism
;
Cartilage, Articular/metabolism/pathology
;
Diagnosis, Differential
;
Human
;
Knee Joint/*pathology
;
Male
;
Metabolic Diseases/metabolism/pathology
;
Shoulder Joint/pathology
10.Clinical Review of the Hematopymetra of Uterus.
Young Seuk CHOI ; Hyung Gun LEE ; Joon Yeon JUN ; Jin Beom KIM ; Sang Bok AHN ; Dong Choon PARK ; Jung Sup PARK ; Joon Mo LEE
Korean Journal of Obstetrics and Gynecology 1997;40(10):2279-2284
Background: Hematopyometra, an accumulation of bloody, purulent material in the ute-rine cavity, is a relatively uncommon event. The incidence is almost 0.01~0.5% in gynec-ologic patients. The most common cause of this condition is interference with the normal drainage of the uterus;endocervical obstruction by malignant disease. Other obstructive causes are the benign tumors in uterus, senile endocervicitis, long-term use of intrauterine device, cervical occlusion after surgery or radiation, intrauterinel infection, and congenital cervical anomaly. Methods: This report was performed to evaluate the hematopyometra patients, who were diagnosed and treated at Catholic University Medical College Hospitals from 1991 to 1995. Forty cases of hematopyometra were retrospectively reviewed by charts, radiologic and pathologic findings concerning with the clinical features. Results: 1) The most frequent age of hematopyometra patients was 50 to 59 years(45 %) and mean age was 63 years old. 2) Four patients(10 %) were at premenopausal period, and remaining 36 patients(90 %) were at the period of menopause(p<0.01). 3) The clinical manifestations of the patients were variable;profuse vaginal discharge(75 %), vaginal ble- eding or spotting(40 %), and lower abdominal pain(30 %). 4) The associating medical cond- itions or possible risk factors of hematopyometra are senile atrophic change(52.5 %), IUD inserted condition(25 %), genital malignant diseases(17.5 %), and uterine myoma(5 %). 5) The bacterial infection are frequently associated with hematopyometra and the causative ag ents are streptococci(50 %), E. coli(42 %), and mixed type(17 %). 6) Eight cases of them showed generalized peritonitis in the preoperative clinical course and three patients had been serious condition by septicemia. 7) The genital malignant diseases are associated with he- matopyomerta in 7 cases(17.5 %) of them(cervical cancer;4 cases, endometrial cancer;2 cases, and ovarian cancer;1 case). 8) All the cancer patients could be followed-up at le-ast for 2 years. Two patients, who were diagnosed for cervical cancer in the stage IIb and III, died of the persistent or recurrent disease in the period of following-up after the pri-mary treatment.
Bacterial Infections
;
Drainage
;
Female
;
Humans
;
Incidence
;
Intrauterine Devices
;
Menopause
;
Middle Aged
;
Peritonitis
;
Premenopause
;
Retrospective Studies
;
Risk Factors
;
Sepsis
;
Uterine Cervical Neoplasms
;
Uterus*